DAA2356 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPB1 |
13.2% Increase Gene Expression Level |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
hippocampus |
Human |
CX3CL1 |
31.6% Decrease Gene Expression Level |
|
DAA1395 |
expressed sequence AU020206 |
Molecular |
hippocampus |
Mouse |
AU020206 |
10.0% Increase Gene Expression Level |
|
DAA2276 |
Fc fragment of IgG binding protein increases with age |
Molecular |
hippocampus |
Human |
FCGBP |
138.3% Increase Gene Expression Level |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB6 |
150.2% Increase Gene Expression Level |
|
DAA1409 |
growth arrest specific 5 |
Molecular |
hippocampus |
Mouse |
Gas5 |
2.0% Increase Gene Expression Level |
|
DAA1429 |
ribonucleotide reductase M2 |
Molecular |
hippocampus |
Mouse |
Rrm2 |
14.0% Decrease Gene Expression Level |
|
DAA1391 |
acyl-CoA synthetase short-chain family member 1 |
Molecular |
hippocampus |
Mouse |
Acss1 |
2.0% Decrease Gene Expression Level |
|
DAA1411 |
general transcription factor II I |
Molecular |
hippocampus |
Mouse |
Gtf2i |
1.0% Decrease Gene Expression Level |
|
DAA2362 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB5 |
184.0% Increase Gene Expression Level |
|
DAA1426 |
RNA binding motif protein 3 |
Molecular |
hippocampus |
Mouse |
Rbm3 |
3.0% Increase Gene Expression Level |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|
DAA2316 |
Major histocompatibility complex, class II, DP alpha 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPA1 |
153.2% Increase Gene Expression Level |
|
DAA2160 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
hippocampus |
Human |
FCGR3B |
647.0% Increase Gene Expression Level |
|
DAA2141 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
hippocampus |
Human |
FCGR1B |
434.2% Increase Gene Expression Level |
|
DAA1442 |
tumor protein D52-like 1 |
Molecular |
hippocampus |
Mouse |
Tpd52l1 |
2.0% Increase Gene Expression Level |
|
DAA2177 |
complement factor H increases with age |
Molecular |
hippocampus |
Human |
CFH |
166.8% Increase Gene Expression Level |
|
DAA2171 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
hippocampus |
Human |
C1QC |
323.4% Increase Gene Expression Level |
|
DAA2277 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
hippocampus |
Human |
FCGR2A |
316.4% Increase Gene Expression Level |
|
DAA2357 |
major histocompatibility complex, class II, DQ beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQB1 |
106.0% Increase Gene Expression Level |
|
DAA2375 |
major histocompatibility complex, class I, C increases with age |
Molecular |
hippocampus |
Human |
HLA-C |
37.8% Increase Gene Expression Level |
|
DAA2169 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
hippocampus |
Human |
C1QA |
243.4% Increase Gene Expression Level |
|
DAA1412 |
HtrA serine peptidase 1 |
Molecular |
hippocampus |
Mouse |
Htra1 |
2.0% Increase Gene Expression Level |
|
DAA1393 |
progressive ankylosis |
Molecular |
hippocampus |
Mouse |
Ank |
1.0% Increase Gene Expression Level |
|
DAA2332 |
HLA-G histocompatibility antigen, class I, G increases with age |
Molecular |
hippocampus |
Human |
HLA-G |
30.6% Increase Gene Expression Level |
|